Search Icon
SideMenu
Home
Press Releases

Biosimilars Council Press Releases

Press Releases
  • Press Releases

Serial Patent Litigation: The Problem is Getting Worse
  • Press Releases

Generic and Biosimilar Medicines Save $467 Billion in 2024
  • Press Releases

Alex Keeton Named Head of the Biosimilars Council, Senior Vice President of Policy
  • Press Releases

AAM Congratulates Dr. Tidmarsh on Appointment as Director of CDER
  • Press Releases

Amphastar to Quadruple Domestic Manufacturing
  • Press Releases

Medicare Drug Price Negotiation has Chilling Effect on Generic and Biosimilar Medicines Development and Availability
  • Press Releases

Patent Thickets and Litigation Abuses Hinder all Biosimilars
  • Press Releases

Groups Join the Biosimilars Council and AAM Letter of Support for Interchangeability Legislation
  • Press Releases

Mark Ratner Joins AAM to Lead Government Relations
  • Press Releases

Hikma Breaks Ground on Expanded U.S. Manufacturing and Announces $1 Billion Investment
  • Press Releases

Eighth Circuit Court Rules Unanimously for AAM in Generic Pricing Appeal
  • Press Releases

Generic and Biosimilar Patent Settlements Save $423 Billion
Load More